A comprehensive view of Weight Management Products. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer packaged goods (CPG) Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bank of America maintains Eli Lilly's buy rating and raises target by US$200 to US$1,000, citing potential for its weight-loss drugs, pipeline of treatments for other ailments; BofA expects Mounjaro's sales to grow to US$60B in 2030 from US$15B in 2021

Elevance Health to launch a digital weight management program centered on new GLP-1 weight loss medications; the program will cater to employer clients of CarelonRx and provide medication management support and a digital companion module

Commentary: Weight-loss drugs could boost revenue of health-forward food chains, and benefit gut-health, fiber-rich, plant-based food companies; larger companies taking note, such as Unilever's plan to double number of products with healthy ingredients

Commentary: Food manufacturers downplaying negative impact of weight-loss drugs on business; Morningstar notes prior health trends like gluten-free, dairy-free and Adkins diet haven't derailed these companies in the past, citing interest waning over time

Goldman Sachs predicts 1% boost in US GDP if 60 million Americans take GLP-1 weight loss drugs by 2028, noting poor health impacts economic growth through missed days at work, early death, and informal caregiving that takes people out of the workforce

Ask us about our Consumer packaged goods (CPG) market view

Trending Chart

Interactive chart with headline count